Navigation Links
Mayo Clinic identifies treatment target for liver cancer recurrence and survival
Date:4/10/2008

These findings were confirmed in mouse models.

This discovery indicates if scientists can decrease the levels or activity of SULF2 in a tumor, they might be able to stop its development. Mayo researchers are exploring use of an agent that mimics heparin and inhibits SULF2. They are also examining whether preventing heparin sulfate synthesis would inhibit tumor growth.

If something has a very broad effect on signaling by growth factors, it may lead to an effective treatment, says Jinping Lai, M.D., Ph.D., a Mayo oncology researcher and the lead author of the study. SULF2 has a number of characteristics that make it an attractive target, such as the fact that it is widely present in tumors. We are exploring a number of options with SULF2 as a focal point for treatment not only in liver cancer, but also in head and neck, pancreas, breast and other types of cancer.

The researchers hope to identify drugs that block SULF2, and seek to thoroughly understand the mechanisms involved, including the determination of what other growth signaling pathways are affected by SULF2. They are also looking further at GPC3 as a potential biomarker for liver cancer or as a possible therapeutic target.

In 2007, Dr. Lai presented information at the annual meeting of the American Association for Cancer Research on the role of SULF2 in survival of patients with head and neck cancer -- the first concrete link to survival of patients with a specific tumor type.


'/>"/>

Contact: Elizabeth Zimmermann
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Radiologists encouraged to look beyond cancer for clinically unseen diseases
3. Clinical depression linked to abnormal emotional brain circuits
4. Preclinical study suggests organ-transplant drug may aid in lupus fight
5. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
6. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
7. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
8. MinuteClinic Becomes Participating Provider with Assurant Health
9. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
10. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
11. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...D, Calif., Jan. 8 (Nas...") announced today that it has submitted an Invest...the US Food and Drug Administration ("FDA" or the ...") study of the Levacor(TM) Ventricular Assist Dev... detailed device information, including design and...
(Date:1/8/2009)...RK, Jan. 8 We hear it everywhere: ... is a carbon footprint, and how can you reduce y...akes is a little thought and planning to bring it ...YSE: SI ) at: http://media.medialink.com/WebNR....n access video, audio, text, graphics and photos f...
(Date:1/8/2009)... Yet another reason to use a tread... Phoenix, AZ (PRWEB) Januar...ff by the medical community warning of America,s r... to disease. The National Cancer Institute complet...ant relationship between excess weight gain and ov...
(Date:1/8/2009)... has been one of the most amazing recovery cases I...Michael Kronenberger, MD, Otolaryngology, Dallas, ...he span of four years, Wally Hogland suffered a st... advanced stage IV cancer. , , "When my doctor ...nd, tears welling up in his eyes at the painful re...
Breaking Medicine News(10 mins):Health News:WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 3Health News:One Man's Determined Journey to Remission and a Renewed Sense of Faith 2
...vestigating the mysterious death of a woman whose ...ood oozed from her ears in an ordeal that started ...Reeling from shock and disbelief, the family of Ju...nswers. Officials have classified the case as an u...
...ature that we want to know answers to everything. ... our own self. How often have we questioned the d...e answers just do not come. Researchers in a break...ystery surrounding heart failure. They found that ...
...ings of a recent study researchers say Cocoa flav...ave an impact on the brain. Cocoa flavonols were f...ain. In a study on 16 healthy young women, resear...g cognitive tasks using functional MRI. The partic...
...ly 27 : Identifying a key gene that controls speci...nding of neurological disorders and lead to better...a to multiple sclerosis, researchers said Wednesda...re (NUS) study has unveiled a new gene that speeds...
Other Medicine News:
(Date:1/6/2009)... -- Pacira Pharmaceuticals, Inc., an,acute care s...hat enrollment,has been completed in two pivotal ...d efficacy of a single intraoperative administrati... postoperative analgesia. , Results from th...rthroplasty (TKA) are expected to provide the prim...
(Date:1/5/2009)... -- Women undergoing in vitro,fertilization (IVF)...arly,pregnancy, but the intramuscular injections ...for patients. Formulations of progesterone medica...jection or vaginal suppository may offer,similar ...th patient well-being a constant focus, Fertility ...
(Date:12/27/2008)...-FirstCall/ -- Warner Chilcott Limited (Nasdaq: ...s and Mayne Pharma International Pty. Ltd. ("Mayne...uits against each of Mutual Pharmaceutical Company...lan") and Impax Laboratories, Inc. ("Impax") in t...or infringement of Mayne,s U.S. Patent No. 6,958,1...
(Date:12/17/2008)...hat normal stem cells can act as the source of tum...nn., Dec. 17 /PRNewswire-USNewswire/ -- Scientis...nswered a central question in cancer biology: whet...m cells are immature cells that can renew themselv...at compose the range of body tissues. In recent ye...
Breaking Medicine Technology:Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 1New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2025 5Training Student Leaders Cuts Peers Smoking Rates 18940 1Training Student Leaders Cuts Peers Smoking Rates 18940 2Health researchers in McGill network receive 2435 5 million in CIHR funding 18937 1Health researchers in McGill network receive 2435 5 million in CIHR funding 18937 2Health researchers in McGill network receive 2435 5 million in CIHR funding 18937 3Passport Health Disaster Response Experts Offer Services to Myanmar Volunteers 18934 1Passport Health Disaster Response Experts Offer Services to Myanmar Volunteers 18934 2
...TTSDALE, Ariz.--(BUSINESS WIRE)--Jun 27, 2007 - An...s of a two-year clinical,study on the impact of ge...hytoestrogen Genistein on Bone Metabolism in Osteo...pears in the current,issue (June 19, 2007) and det...dietary management of osteopenia and,osteoporosis....
...tement by Sandra C. Raymond, President & CEO o...N, June 27, 2007 /PRNewswire-USNewswire/ -- The Lu...million Americans,with lupus have been awaiting th...rials for CellCept(R), a potential treatment for,l...ceutical,Company. Development of new treatments fo...
Other Medicine Technology:New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 2New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 3Lupus Foundation of America Statement on Results for Clinical Study,of CellCept Released by Aspreva Pharmaceutical Company 2
...las D Fibertom is a 60 watt diode continuous wave ...ower Bar technology and 940 nm wavelength make thi...tment for varicose veins and a variety of surgical...s unique safety features including the LPS, Light ...
Roths 28 Hue test studies the characteristic axies of dyschromatopsia similar to the Farnsworth D15, however this 28 hue test provides a greater degree of sensitivity. Case comes with a transparent
...sc test for detecting and grading acquired color d...ive estimation of saturation thresholds for bluish...for differences between normal and acquired vision...tic plates, discriminates between congenital and a...
Gas powered, single use, reloadable, laparoscopic 15 mm linear cutting stapler for resection, transection and anastomosis with titanium staples.
Medicine Products: